Beauty Health (SKIN) Stock Price
Beauty Health Price
Beauty Health stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Beauty Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Beauty Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Beauty Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Beauty Health Price |
|---|---|
| 2/26/2026 | 1.00 USD |
| 2/25/2026 | 0.92 USD |
| 2/24/2026 | 0.90 USD |
| 2/23/2026 | 0.94 USD |
| 2/20/2026 | 0.95 USD |
| 2/19/2026 | 0.99 USD |
| 2/18/2026 | 1.00 USD |
| 2/16/2026 | 1.00 USD |
| 2/12/2026 | 1.04 USD |
| 2/11/2026 | 1.04 USD |
| 2/10/2026 | 1.06 USD |
| 2/9/2026 | 1.16 USD |
| 2/8/2026 | 1.21 USD |
| 2/5/2026 | 1.28 USD |
| 2/4/2026 | 1.29 USD |
| 2/3/2026 | 1.45 USD |
| 2/2/2026 | 1.41 USD |
| 2/1/2026 | 1.50 USD |
Beauty Health Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Beauty Health Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 119 | 260 | 365 | 397 | 334 | 302 | 315 | 325 | 353 |
| – | – | 118.49 | 40.38 | 8.77 | -15.87 | -9.58 | 4.30 | 3.17 | 8.62 |
| – | 56.30 | 69.62 | 68.49 | 48.61 | 62.87 | 69.54 | 66.67 | 64.62 | 59.49 |
| 210 | 67 | 181 | 250 | 193 | 210 | 210 | 210 | 210 | 210 |
| 0 | -29 | -375 | 44 | -100 | -29 | -7 | -13 | -23 | 26 |
| – | – | 1,193.10 | -111.73 | -327.27 | -71.00 | -75.86 | 85.71 | 76.92 | -213.04 |
| 123.83 | 34.3 | 150.6 | 148.5 | 131.68 | 123.83 | 123.83 | 123.83 | 123.83 | 123.83 |
| – | – | – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Beauty Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Beauty Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Beauty Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Beauty Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Beauty Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Unlock the full history with 30+ years of data and forecast estimates.
Unlock all data — PROBeauty Health Stock Quarterly Figures
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4e | 2026 Q1e | 2026 Q2e | 2026 Q3e | 2026 Q4e | 2027 Q1e | 2027 Q2e | 2027 Q3e | 2027 Q4e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 | 0 | 119 | 47 | 66 | 68 | 77 | 75 | 103 | 88 | 98 | 86 | 117 | 97 | 96 | 81 | 90 | 78 | 83 | 69 | 78 | 70 | 79 | 71 | 81 | 74 | 83 | 77 | 87 | 78 | 86 |
| – | – | – | -60.50 | 40.43 | 3.03 | 13.24 | -2.60 | 37.33 | -14.56 | 11.36 | -12.24 | 36.05 | -17.09 | -1.03 | -15.63 | 11.11 | -13.33 | 6.41 | -16.87 | 13.04 | -10.26 | 12.86 | -10.13 | 14.08 | -8.64 | 12.16 | -7.23 | 12.99 | -10.34 | 10.26 |
| 28.57 | – | 56.30 | 65.96 | 71.21 | 67.65 | 72.73 | 66.67 | 67.96 | 69.32 | 66.33 | 62.79 | 57.26 | -12.37 | 86.46 | 59.26 | 60.00 | 51.28 | 68.67 | 69.57 | 62.82 | 64.29 | 56.96 | 63.38 | 55.56 | 60.81 | 54.22 | 58.44 | 51.72 | 57.69 | 52.33 |
| 4 | 45 | 67 | 31 | 47 | 46 | 56 | 50 | 70 | 61 | 65 | 54 | 67 | -12 | 83 | 48 | 54 | 40 | 57 | 48 | 49 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| -10 | 0 | -29 | -3 | -139 | -215 | -17 | 31 | 6 | 0 | 3 | -20 | 3 | -73 | -9 | 0 | 0 | -18 | -10 | -10 | 19 | -11 | -6 | -6 | -2 | -5 | -2 | -5 | -3 | -6 | -3 |
| – | – | – | -89.66 | 4,533.33 | 54.68 | -92.09 | -282.35 | -80.65 | – | – | -766.67 | -115.00 | -2,533.33 | -87.67 | – | – | – | -44.44 | – | -290.00 | -157.89 | -45.45 | – | -66.67 | 150.00 | -60.00 | 150.00 | -40.00 | 100.00 | -50.00 |
| 34.5 | 57.5 | 34.3 | 125.4 | 143 | 133.5 | 201.9 | 152.7 | 151.7 | 150.8 | 138.1 | 132.6 | 132.7 | 132.9 | 128.68 | 123.12 | 123.72 | 124.06 | 124.42 | 125.08 | 140.29 | 126.89 | 126.89 | 126.89 | 126.89 | 126.89 | 126.89 | 126.89 | 126.89 | 126.89 | 126.89 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Beauty Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Beauty Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Beauty Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Beauty Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Beauty Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Unlock the full history with 30+ years of data and forecast estimates.
Unlock all data — PROBeauty Health stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Beauty Health Stock Sales Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Beauty Health business model
Beauty Health SWOT Analysis
Strengths
Beauty Health Co has a strong brand reputation in the beauty and health industry.
The company offers a wide range of high-quality beauty and health products.
Beauty Health Co has established a strong distribution network across various channels.
Weaknesses
The company heavily relies on outsourcing for its manufacturing processes.
There have been occasional quality control issues with certain products.
Beauty Health Co lacks strong online presence and e-commerce capabilities.
Opportunities
The growing demand for natural and organic beauty and health products presents an opportunity for Beauty Health Co to expand its product line.
The company can leverage social media and online platforms to reach a wider customer base.
International expansion can open up new markets and increase revenue streams for Beauty Health Co.
Threats
Competition in the beauty and health industry is intensifying, with new entrants and established players constantly innovating.
Changes in regulations and compliance standards can pose challenges for Beauty Health Co.
Economic downturns and fluctuations in consumer spending can impact the company's sales and profitability.
Beauty Health Segments
Beauty Health Revenue by Segment (1/3)
3 Years
Max
Details
Beauty Health Revenue by Segment (2/3)
3 Years
Max
Details
Beauty Health Revenue by Segment (3/3)
Max
Details
Beauty Health Revenue by Region
3 Years
Max
Details
Beauty Health Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Beauty Health historical P/E ratio, EBIT multiple, and P/S ratio
Beauty Health shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Beauty Health forecasts and price targets in March 2026
| Δ MOM Price Target | 4.84 % |
| Buy | 7.14 % (1) |
| Hold | 57.14 % (8) |
| Sell | 35.71 % (5) |
| 12M Price Target | 1.66 |
| Last Price | 1.69 |
| Currency | USD |
| 12M Return Potential | -1.72 % |
| LTM Return | 0 % |
Beauty Health Earnings Estimates
Beauty Health Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 3/18/2026 | -0.05USD | 79.31 MUSD | 2025 Q4 |
| 8/7/2025 | -0.05USD | 75.99 MUSD | 2025 Q2 |
| 11/11/2024 | -0.12USD | 75.55 MUSD | 2024 Q3 |
| 5/8/2024 | -0.04USD | 89.78 MUSD | 2024 Q1 |
| 2/26/2024 | -0.07USD | 90.66 MUSD | 2023 Q4 |
| 11/6/2023 | 0.07USD | 112.17 MUSD | 2023 Q3 |
| 8/7/2023 | 0.04USD | 112.48 MUSD | 2023 Q2 |
| 11/8/2022 | 0.02USD | 81.76 MUSD | 2022 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Beauty Health stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Beauty Health shareholders
| % | Name |
|---|---|
26.94132% | |
14.95860% | |
10.38667% | |
7.10487% | |
5.35446% | |
4.61817% | |
4.58850% | |
2.61716% | |
1.85967% | |
1.76890% |
Beauty Health Executives and Management Board
Mr. Michael Monahan
(53)Chief Financial Officer
Mr. Brenton Saunders
(55)Chairman of the Board · since 2021
Ms. Michelle Kerrick
(62)Independent Director
Mr. Douglas Schillinger
(51)Independent Director
Mr. Brian Miller
(50)Independent Director
Beauty Health Supply Chain
Beauty Health Research
SoonDeep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.
Research reports are coming soon
We're building institutional-grade equity research for Beauty Health and thousands of other companies.
Most common questions regarding Beauty Health
The business model of Beauty Health Co revolves around offering a range of beauty and healthcare products to consumers. The company primarily focuses on developing and manufacturing innovative solutions that cater to various aspects of personal care and wellness. Beauty Health Co aims to deliver high-quality products that enhance the physical and mental well-being of individuals. By combining scientific research, advanced technology, and expert formulations, the company strives to meet the diverse needs of its customer base. With a strong emphasis on quality and customer satisfaction, Beauty Health Co continually enhances its product portfolio to provide innovative and effective solutions in the beauty and healthcare industry.
Beauty Health stock
Beauty Health Peer Group
Beauty Health Ticker
Beauty Health FIGI
All fundamentals about Beauty Health
Our stock analysis for Beauty Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beauty Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.